secwatch.observer — SEC 8-K summary
======================================

Issuer:     Disc Medicine, Inc. (IRON)
CIK:        0001816736
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0000950170-24-123718
Event type: debt
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Disc Medicine secures up to $200M non-dilutive debt facility from Hercules Capital
--------------------------------------------------------------------------------

- $200M senior secured term loan facility from Hercules Capital; $30M drawn at closing.
- Up to $80M additional available at Disc's sole discretion through second-half 2026.
- Remaining $90M subject to milestone achievement or lender consent.
- Interest-only for at least 48 months, extendable to 60 months; matures November 2029.
- Proceeds to support bitopertin EPP confirmatory trial, DISC-0974 MF/NDD-CKD studies, and DISC-3405 PV trial.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816736/000095017024123718/0000950170-24-123718-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816736/000095017024123718/iron-20241106.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-123718

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer